|
Human Protein Atlas
mrna expression data for 37 different normal tissues Mrna Expression Data For 37 Different Normal Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/mrna+expression+data+for+37+different+normal+tissues/pmc07904710-43-10-17 Average 90 stars, based on 1 article reviews
mrna expression data for 37 different normal tissues - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
normal tissue data Normal Tissue Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/normal+tissue+data/pmc07212270__mmc3-559-10-7 Average 90 stars, based on 1 article reviews
normal tissue data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
hcc and normal liver tissues expression data ![]() Hcc And Normal Liver Tissues Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/hcc+and+normal+liver+tissues+expression+data/pmc07330124-139-8-16 Average 90 stars, based on 1 article reviews
hcc and normal liver tissues expression data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Broad Institute Inc
poly(a)+ rna-seq data for normal healthy tissues ![]() Poly(a)+ Rna Seq Data For Normal Healthy Tissues, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/poly+a+++rna+seq+data+for+normal+healthy+tissues/pmc08919705-279-1-12 Average 90 stars, based on 1 article reviews
poly(a)+ rna-seq data for normal healthy tissues - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
normal tissue scrnaseq data ![]() Normal Tissue Scrnaseq Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/normal+tissue+scrnaseq+data/pm37802054-250-6-11 Average 90 stars, based on 1 article reviews
normal tissue scrnaseq data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
normal tissue fpkm data ![]() Normal Tissue Fpkm Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/normal+tissue+fpkm+data/pmc11994455-462-0-8 Average 90 stars, based on 1 article reviews
normal tissue fpkm data - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
immunohistochemistry data of args in normal lung tissue and lusc tumor tissue ![]() Immunohistochemistry Data Of Args In Normal Lung Tissue And Lusc Tumor Tissue, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/immunohistochemistry+data+of+args+in+normal+lung+tissue+and+lusc+tumor+tissue/pmc11499073-96-3-14 Average 90 stars, based on 1 article reviews
immunohistochemistry data of args in normal lung tissue and lusc tumor tissue - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
subcellular localization of tgif2 protein in sh-sy5y cell line ![]() Subcellular Localization Of Tgif2 Protein In Sh Sy5y Cell Line, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/mrna+expression+data+of+tgif2+in+normal+tissues/pmc11020094-123-13-22 Average 90 stars, based on 1 article reviews
subcellular localization of tgif2 protein in sh-sy5y cell line - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
immunohistochemical data of 9 hub genes in luad or normal lung tissue ![]() Immunohistochemical Data Of 9 Hub Genes In Luad Or Normal Lung Tissue, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/immunohistochemical+data+of+9+hub+genes+in+luad+or+normal+lung+tissue/pmc08841557-96-8-17 Average 90 stars, based on 1 article reviews
immunohistochemical data of 9 hub genes in luad or normal lung tissue - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GenXPro Inc
super-sage data for malat1 expression in pancreas carcinoma and pancreatitis compared to normal pancreas tissue ![]() Super Sage Data For Malat1 Expression In Pancreas Carcinoma And Pancreatitis Compared To Normal Pancreas Tissue, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/super+sage+data+for+malat1+expression+in+pancreas+carcinoma+and+pancreatitis+compared+to+normal+pancreas+tissue/pmc03661464-101-9-18 Average 90 stars, based on 1 article reviews
super-sage data for malat1 expression in pancreas carcinoma and pancreatitis compared to normal pancreas tissue - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
normal tissue ihc data v.23.0 ![]() Normal Tissue Ihc Data V.23.0, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/normal+tissue+ihc+data+v+23+0/bio_rxiv__2024__12__11__627962-372-0-7 Average 90 stars, based on 1 article reviews
normal tissue ihc data v.23.0 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human Protein Atlas
immunohistochemical data of breast cancer and normal tissues ![]() Immunohistochemical Data Of Breast Cancer And Normal Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/normal+tissue+data/immunohistochemical+data+of+breast+cancer+and+normal+tissues/pmc04813709-374-3-11 Average 90 stars, based on 1 article reviews
immunohistochemical data of breast cancer and normal tissues - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Genetics
Article Title: Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
doi: 10.3389/fgene.2020.00634
Figure Lengend Snippet: Mutational landscape of SMGs in HCC. (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.
Article Snippet: After identifying
Techniques: Mutagenesis, Expressing, Immunohistochemical staining, Staining
Journal: Frontiers in Genetics
Article Title: Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
doi: 10.3389/fgene.2020.00634
Figure Lengend Snippet: Mutation signatures operative in HCC. (A) Single nucleotide variation classification: different colors represent different types of variation. (B) Variant classification: different colors represent different variant classifications. (C) Mutational signatures: spectrum of total SNVs and three mutational signatures in the context of the 96 base-pair substitutions. Because the dynamic range for the signatures is large, the upper limits of the y-axis used for each signature are different. (D) SMG mutation rate in three groups of HCC samples. (E) Unsupervised clustering of mutations in SMGs and focal SCNAs. (F) Differences in mutational patterns between APOBEC-enriched and non-APOBEC-enriched samples.
Article Snippet: After identifying
Techniques: Mutagenesis, Variant Assay
Journal: Cancer Reports
Article Title: A Four‐Gene Autophagy‐Related Prognostic Model Signature and Its Association With Immune Phenotype in Lung Squamous Cell Carcinoma
doi: 10.1002/cnr2.70000
Figure Lengend Snippet: Results of differentially expressed analysis on ARGs and enrichment analysis of DE‐ARGs. (A) A heatmap of 48 differentially expressed ARGs between 326 LUSC samples and 32 normal controls. Each line represents a DE‐ARG and each row means a sample. The expression levels of genes are displayed with colors in each cell (red for high and blue for low). (B) The volcano plot of differentially expressed ARGs between LUSC samples and normal controls. (C) The enriched significant KEGG signal pathways of DE‐ARGs. The color represents the statistical significance of the term. The length indicates the counts of enriched genes.
Article Snippet: Immunohistochemistry data of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: The expression level of TGIF2 in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing, Comparison
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Clinical characteristics of glioma patients.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques:
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Logistic analysis of the association between TGIF2 expression and clinical characteristics.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Associations between TGIF2 expression and various clinicopathologic characteristics in glioma. (A) Age. (B) IDH status. (C) 1p/19q codeletion status. (D) Primary therapy outcome. (E) OS events. (F) DSS events. (G) PFI events. (H) WHO grade. (I) Histological type. (J) Gender. (K) Race. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Prognostic value of TGIF2 expression level in glioma. (A) TGIF2 expression distribution and survival status. (B) Time-dependent ROC curves for TGIF2 expression in glioma. (C) Forest plot of OS by multivariate Cox regression analysis in glioma from TCGA database. (D) The nomogram for predicting 1-, 3-, or 5-year OS rates in patients with glioma. (E) The calibration curves for the nomogram.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Univariate and multivariate cox regression analyses of clinical characteristics associated with overall survival.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques:
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Correlations between TGIF2 expression level and OS in different clinicopathologic subgroups of glioma by Kaplan-Meier survival curve analysis. (A) Age ≤ 60. (B) Age > 60. (C) Gender: Male. (D) Gender: Female. (E) Race: White. (F) WHO grade: G3. (G) 1p/19q codeletion: non-codeletion. (H) Histological type: Astrocytoma. (I) Primary therapy outcome: PD.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Functional enrichment analysis of DEGs between TGIF2 high and low expression groups. (A) The volcano plot of DEGs. Red represents upregulated, blue represents downregulated genes. (B) GO and KEGG pathway enrichment analysis of DEGs. (C–H) GSEA functional enrichment analysis.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Functional Assay, Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Correlations between TGIF2 expression and immune cell infiltration in glioma. (A–C) Comparison of StromalScore, ImmuneScore, and EstimateScore between TGIF2 high and low expression groups. (D, E) Comparison of immune cell enrichment scores in high and low TGIF2 expression groups. (F) The lollipop chart showing the correlations between the relative abundances of 24 immune cells and TGIF2 expression levels. (G–N) Scatterplots demonstrating the positive correlation of TGIF2 expression with Th2 cells, macrophages, eosinophils, and neutrophils, and the negative correlation with mast cells, NK CD56bright cells, pDC cells, and TFH cells. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing, Comparison
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Analysis of genes coexpressed with TGIF2 in glioma. (A) Heatmap showing the 30 genes in glioma that were 15 positively and 15 negatively related to TGIF2. (B) PPI network of top 50 protein-coding genes positively and negatively correlated with TGIF2. (C) The top 10 hub genes of the PPI network in (B) . (D) The expression levels of the top 10 hub genes in normal and glioma tissues in TCGA and GTEx database. ∗∗∗p < 0.001.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Expressing
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Knockdown of TGIF2 inhibits glioma cell invasion, migration and EMT in vitro . (A) Bar graph demonstrating the efficiency of siRNA knockdown of TGIF2 mRNA in U251 cells by RT-qPCR. (B) Western blot assay showing that siRNA effectively knocked down TGIF2 protein, and siTGIF2 downregulated N-cadherin protein expression in U251 cells. (C) Transwell assay demonstrating changes in the number of cells invaded after knockdown of TGIF2. Scale bar, 500 μm. (D) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-inhibited group and control group at 0h and 24h after scratching. Scale bar, 500 μm. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Knockdown, Migration, In Vitro, Quantitative RT-PCR, Western Blot, Expressing, Transwell Assay, Control
Journal: Frontiers in Immunology
Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi: 10.3389/fimmu.2024.1356833
Figure Lengend Snippet: Knockout of TGIF2 suppresses glioma cell invasion, migration and EMT. (A) The gRNA sequences designed targeting exon 2 of TGIF2. (B) The editing efficiency of gRNA33 and gRNA140 on TGIF2 was verified in 293T cells utilizing Sanger sequencing. (C) TGIF2-gRNA33 in the UCSC browser. (D) Western blot assay showing the knockout efficiency of TGIF2 protein. WT, Wild type; KO, Knockout. (E) Transwell assays showing changes in the number of cells invaded after knockout of TGIF2. Scale bar, 500 μm. (F) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-knockout group and control group at 0h and 24h after scratching. Scale bar, 250 μm. ∗p < 0.05.
Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of
Techniques: Knock-Out, Migration, Sequencing, Western Blot, Control
Journal: bioRxiv
Article Title: Pan-cancer N -glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers
doi: 10.1101/2024.12.11.627962
Figure Lengend Snippet: (A &B) Contingency tables used to determine the likelihood of detecting a clinical (A) ADC and (B) CAR T target in the PDX human tumor N -glycoproteome against all other surface proteins in the human proteome. P-values were calculated using a Fisher’s exact test. (C) Normal tissue toxicity scoring system. (D) Distribution of full body normal tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Jiang et al., (left), Human Protein Atlas (middle) and GTEx RNA-seq data (right). (E) Distribution of normal brain tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Tushaus et al., (left), Human Protein Atlas brain IHC data (middle) and Human Protein Atlas brain RNA-seq data (right). (F) Distribution of normal heart tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Berg Luecke et al., (left) and Doll et al., (middle & right). (D-F) P-values from unpaired Mann-Whitney U tests.
Article Snippet:
Techniques: Glycoproteomics, RNA Sequencing, MANN-WHITNEY